Seems ATHX among the public companies in the hot seat for taking Covid 19 government funds.
Taking $1 million even though they just raised $60 million through a offering.
Curious if pressure will force a return of the funds.
>>>Another company which tapped into the PPP was Ohio-based biotech Athersys, which received $1 million through the program despite raising nearly $60 million in a Monday stock offering after its shares have nearly doubled YTD.<<<
It looks that the development of a vaccine against COVID-19 will take time. In that case the major medical objecive is to fnd a way to treat or prevent the development of ARDS. ARDS is what kills, the virus simply instgates it through the initiation of a massve immune system response/activation. If an effective treatment aganst ARDS is found it will behuge . ARDS is a major killer even in normal times.
I hope that ATHX can regulate the immune system in a positive way. Personally I am looking at companies that regulate the complement system (eg. MASP 2) which is a main activater of the immune system.
Agree again. Even before Covid-19 ARDS had a stubborn 40% mortality rate.
It will take quite some time before someone can get approval for a treatment for ARDS. I believe even Cytori had some positive data on the subject way back when. Never pursued but I question pretty much everything related to what was Cytori these days.